Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Models for Drug Testing: Organoids & Tissue Chips 2022

3D-Models for Drug Testing: Organoids & Tissue Chips 2022

Date: Tuesday, 13 September 2022 - Wednesday, 14 September 2022
Location: Seattle

Conference Chair

Albert Folch

Albert Folch
Professor of Bioengineering, University of Washington

Plenary Speakers

Nancy Allbritton

Nancy Allbritton
Frank and Julie Jungers Dean of the College of Engineering and Professor of Bioengineering, University of Washington in Seattle

Daniel Chiu

Daniel Chiu
A. Bruce Montgomery Professor of Chemistry, University of Washington

Danilo Tagle

Danilo Tagle
Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)

Keynote Speakers

Steven C. George

Steven C. George
Edward Teller Distinguished Professor and Chair, Department of Biomedical Engineering, University of California-Davis

Cole DeForest

Cole DeForest
Weyerhaeuser Endowed Professor , University of Washington

Elisabeth Verpoorte

Elisabeth Verpoorte
Chair of Analytical Chemistry and Pharmaceutical Analysis, University of Groningen

John Rogers

John Rogers
Simpson/Querrey Professor of Materials Science and Engineering, Northwestern University

Matthias von Herrath

Matthias von Herrath
Vice President and Senior Medical Officer, Novo Nordisk, Professor, La Jolla Institute

Noo Li Jeon

Noo Li Jeon
Professor, Seoul National University


SelectBIO is pleased to welcome you all to the 3D-Models for Drug Testing: Organoids and Tissue Chips 2022 to be held on-site in-person live in beautiful downtown Seattle.

This conference is held co-located and concurrently with the SelectBIO Extracellular Vesicles 2022 Conference.  All attendees receive full access to both tracks and the networking opportunities during the Food & Beverage events.

This 3D-Models: Organoids and Tissue Chips 2022 Conference focuses on the emerging tools for the ex vivo recapitulation of organ systems on-board microfluidic chips and their utility for modeling physiological and disease processes in a controlled environment. Additionally, technologies and tools for fabricating such systems ex vivo including organoids and tissue chips will be addressed during the conference.

There is a co-located exhibition with companies from around the world exhibiting on-site in person at the conference -- the focus therefore is on presentations from academic and industry speakers and exhibits by the companies offering tools, technologies and services to the field.

**Proof of Covid-19 Vaccination Required in Order to Participate On-Site at this Event.  Participants Not Vaccinated for Covid-19 Can Participate Virtually at this Event. Masks required onsite for all participants.**

Agenda Topics

  • Bioprinting using Microfluidics-based Approaches
  • Building Organoids from Various Tissue Classes (Brain, Gut, Lung, etc.) and Studies on these Organoids
  • Emerging Technologies for Reproducible Production of Organoids
  • Organ-on-a-Chip/Body-on-a-Chip Assembly using Microfluidics: Tools and Approaches
  • Spheroids -- 3D Aggregates of Cells in Culture: Technologies and Applications
  • Tissue-on-a-Chip Applications for Drug Discovery and Toxicity Screening

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager

Confirmed Speakers to date

Jeffrey Borenstein, Group Leader, Synthetic Biology; Director, Biomedical Engineering Center, Draper
Christopher Easley, C. Harry Knowles Professor, Auburn University
Thomas Gervais, Professor of Engineering Physics and Biomedical Engineering, Ecole Polytechnique de Montréal
Ali Khademhosseini, CEO and Founding Director, Terasaki Institute for Biomedical Innovation
Viraj Mehta, Research Fellow, Indian Institute of Technology, Hyderabad
Mehdi Nikkhah, Associate Professor of Bioengineering, Arizona State University
Brian O'Grady, Post-Doctoral Researcher, Vanderbilt University
Hemdeep Patel, President, Co-Founder, CADworks3D
Rebecca Pompano, Associate Professor, Carter Immunology Center, University of Virginia
Haley Pugsley, Manager and Senior Scientist, Luminex Corporation
Kelly Stevens, Associate Professor, Department of Bioengineering, University of Washington
Yen-Ting Tung, Research Fellow, 3D Tissue Bioprinting Group, National Center for Advancing Translational Sciences (NCATS)
Ying Zheng, Associate Professor, Department of Bioengineering, University of Washington

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2022-09-13 00:00:002022-09-14 00:00:00Europe/London3D-Models for Drug Testing: Organoids and Tissue Chips 20223D-Models for Drug Testing: Organoids and Tissue Chips 2022 in